Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
ENSC vs OLB: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
ENSC Captures Overall Composite Edge (53.4 HOLD vs 48.6 HOLD), While OLB Leads 3–2 on Growth & Valuation Pillars
ENSC Overall Winner
6-Pillar Tally: ENSC 2 – 3 OLB (1 Tie)
Matrix Metrics: ENSC 6 – 3 OLB
As of Nov 20, 2026, Ensysce Biosciences, Inc. (ENSC) captures the overall head-to-head institutional edge over The OLB Group, Inc. (OLB) on higher Unified Composite conviction (53.4/100 HOLD vs. 48.6/100 HOLD) after splitting the core matrix 6–3 (led by Valuation Multiples, Growth & Scale), while OLB wins 3–2 across the 6-pillar growth and valuation breakdown. ENSC trades at $0.36 (0.8x Forward P/E, -281.3% operating margin) versus OLB at $0.12 (N/M Forward P/E, -73.3% operating margin).
- Growth vs. Quality Trade-Off: ENSC earns the overall head-to-head edge with a stronger Unified Composite Score (53.4/100 HOLD vs. OLB 48.6/100 HOLD) and 0.98β · 79% Vol risk profile, whereas OLB leads top-line expansion (-43.6% YoY revenue growth, N/M PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates.
- Technical & Structure Timing Caution: ENSC is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 39.7); meanwhile OLB is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 29.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Executive Snapshot Side-by-Side Composite Ratings & Technical Regime
Ask Alpha AI About ENSC vs OLB
ENSC
Head-to-Head Winner
Ensysce Biosciences, Inc. Common Stock
$0.36
-0.17% 1D
Market Cap
$7.0M
TTM Revenue
$4.5M
Forward P/E
0.8x
Beta / 30D Vol
0.98β · 79% Vol
Unified Composite Score
53.4
HOLD
Tech 50.0
Fund 62.0
Flow 50.0
Mom 60.0
Weinstein Technical Phase
Markdown · Sell / avoid
OLB
The OLB Group, Inc. Common Stock
$0.12
-4.33% 1D
Market Cap
$3.8M
TTM Revenue
$7.0M
Forward P/E
N/M
Beta / 30D Vol
1.80β · 120% Vol
Unified Composite Score
48.6
HOLD
Tech 48.0
Fund 46.0
Flow 50.0
Mom 60.0
Weinstein Technical Phase
Markdown · Sell / avoid
6-Pillar Scorecard Institutional Category Breakdown (ENSC 2 – 3 OLB)
1. Valuation Multiples
ENSC
Forward P/E
0.8x
N/M
Trailing P/E
0.8x
N/M
PEG Ratio
N/M
N/M
EV / Revenue
1.4x
0.4x
2. Growth & Scale
ENSC
Revenue Growth (YoY)
-15.1%
-43.6%
Earnings Growth (YoY)
+0.0%
+0.0%
TTM Revenue (USD)
$4.5M
$7.0M
Market Cap
$7.0M
$3.8M
3. Profitability & Quality
OLB
Gross Margin
N/A
-30.9%
Operating Margin
-281.3%
-73.3%
Net Profit Margin
-280.5%
-68.2%
Return on Equity (ROE)
-1295.1%
-70.8%
4. Balance Sheet & Cash Flow
OLB
Cash Generation (TTM)
-$9.7M
-$2.6M
Cash Flow Margin
N/A
-36.3%
Net Cash / Leverage
-$499,633 Net Debt
$1.1M Net Cash
Dividend Yield
None (0.00%)
None (0.00%)
5. Options & Positioning
Tie
Options Structure Phase
UNCLASSIFIED
UNCLASSIFIED
Current IV / %ile
N/A (N/A)
N/A (N/A)
Put/Call OI Skew
N/A
N/A
OBV Trend / Tech Phase
NEUTRAL · Markdown
NEUTRAL · Markdown
6. R&D & Supply-Chain Moat
OLB
OpEx & R&D Intensity
N/A
42.4% of Rev ($3.0M)
90D R&D Disclosures
0 papers
0 papers
Competitive Moat
Cyclical / Execution-Driven Positioning
Cyclical / Execution-Driven Positioning
Supply-Chain Role
Biotechnology Operator
Software - Infrastructure Operator
Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table
Core Matrix Wins: ENSC (6) vs OLB (3)| Institutional Metric | ENSC | OLB | Criterion | Row Edge |
|---|---|---|---|---|
| Market Capitalization | $7.0M | $3.8M | Tie | |
| Trailing P/E Ratio | 0.8x | N/M | ENSC | |
| Forward P/E Ratio | 0.8x | N/M | ENSC | |
| Revenue Growth (YoY) | -15.1% | -43.6% | ENSC | |
| Operating Margin (TTM) | -281.3% | -73.3% | OLB | |
| Net Profit Margin | -280.5% | -68.2% | OLB | |
| Return on Equity (ROE) | -1295.1% | -70.8% | OLB | |
| 52-Week Range Position | 8% ($0–$2) | 0% ($0–$2) | ENSC | |
| Beta / 30D Volatility | 0.98β · 79% Vol | 1.80β · 120% Vol | ENSC | |
| Unified Institutional Score | 53.4 / 100 (HOLD) | 48.6 / 100 (HOLD) | ENSC | |
| Trailing 12M Revenue (USD) | $4.5M | $7.0M | Scale | |
| Gross Profit Margin (TTM) | N/A | -30.9% | Quality | |
| PEG Ratio & EV / Revenue | N/M PEG · 1.4x EV/Rev | N/M PEG · 0.4x EV/Rev | Valuation | |
| Cash Flow & Balance Sheet | -$9.7M (-$499,633 Net Debt) | -$2.6M ($1.1M Net Cash) | Solvency |
Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)
1M Horizon
ENSC +33.71 pp
3M Horizon
ENSC +61.06 pp
6M Horizon
ENSC +88.42 pp
1Y Horizon
ENSC +7.03 pp
Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | ENSC Revenue | OLB Revenue | ENSC Op. Margin | OLB Op. Margin | Margin Leader |
|---|---|---|---|---|---|
| FY2018 | N/A | $10M | N/A | 5.9% | OLB |
| FY2019 | N/A | $10M | N/A | -2.6% | OLB |
| FY2020 | $0M | $10M | -41.0% | -7.5% | OLB |
| FY2021 | $0M | $20M | -562.7% | -28.5% | OLB |
| FY2022 | $0M | $30M | -959.9% | -26.9% | OLB |
| FY2023 | $0M | $30M | -480.5% | -76.8% | OLB |
| FY2024 | $10M | $10M | -129.2% | -90.9% | OLB |
| FY2025 | $10M | $10M | -202.1% | -59.5% | OLB |
Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor
Live Options Phase Tracker
ENSC
UNCLASSIFIED
Current IV
N/A
IV Percentile
N/A
Put/Call OI Skew
N/A
IV Regime
Unclassified
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
NEUTRAL
OBV Flow
NEUTRAL
Exact ENSC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
OLB
UNCLASSIFIED
Current IV
N/A
IV Percentile
N/A
Put/Call OI Skew
N/A
IV Regime
Unclassified
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
NEUTRAL
OBV Flow
NEUTRAL
Exact OLB Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity
Corporate R&D & Foundry Leaderboard
ENSC Moat Profile
Cyclical / Execution-Driven Positioning
Biotechnology Operator
OpEx & R&D Reinvestment
N/A
90D Engineering Disclosures
0 Published
OLB Moat Profile
Cyclical / Execution-Driven Positioning
Software - Infrastructure Operator
OpEx & R&D Reinvestment
42.4% of Rev ($3.0M)
90D Engineering Disclosures
0 Published
Investor FAQ ENSC vs OLB Key Questions & Quantitative Answers
As of Nov 20, 2026, Ensysce Biosciences, Inc. (ENSC) captures the overall head-to-head institutional edge over The OLB Group, Inc. (OLB) on higher Unified Composite conviction (53.4/100 HOLD vs. 48.6/100 HOLD) after splitting the core matrix 6–3 (led by Valuation Multiples, Growth & Scale), while OLB wins 3–2 across the 6-pillar growth and valuation breakdown. ENSC trades at $0.36 (0.8x Forward P/E, -281.3% operating margin) versus OLB at $0.12 (N/M Forward P/E, -73.3% operating margin). Growth vs. Quality Trade-Off: ENSC earns the overall head-to-head edge with a stronger Unified Composite Score (53.4/100 HOLD vs. OLB 48.6/100 HOLD) and 0.98β · 79% Vol risk profile, whereas OLB leads top-line expansion (-43.6% YoY revenue growth, N/M PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: ENSC is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 39.7); meanwhile OLB is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 29.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
ENSC leads the Growth & Scale pillar: ENSC posts -15.1% YoY revenue growth and +0.0% YoY earnings growth on $4.5M TTM revenue (N/A gross margin, -281.3% operating margin), compared with OLB at -43.6% YoY revenue growth and +0.0% YoY earnings growth on $7.0M TTM revenue (-30.9% gross margin, -73.3% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), ENSC cumulative revenue shifted +0.0% while OLB shifted +0.0%. In operating R&D and SG&A reinvestment, ENSC deploys N/A (0 90-day corporate R&D disclosures) versus 42.4% of Rev ($3.0M) (0 disclosures) for OLB.
ENSC screens cheaper on headline valuation multiples. ENSC trades at 0.8x Forward P/E, 0.8x Trailing P/E, N/M PEG, and 1.4x EV/Revenue (unreported FCF margin), whereas OLB trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.4x EV/Revenue (-36.3% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ENSC (-1295.1% ROE) versus OLB (-70.8% ROE) capital efficiency.
In options market volatility and institutional positioning, ENSC carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.98β · 79% Vol realized risk). By comparison, OLB carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.80β · 120% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Launch Custom Ticker Comparison →
OLB vs ENSC · Reverse Pair
ENSC vs QNRX
· Sector Peer
INTC vs AMD
· x86 & Data Center CPU
NVDA vs AMD
· AI Accelerators
TSM vs ASML
· Foundry & Lithography
MSFT vs GOOGL
· Hyperscale Cloud & AI
AAPL vs META
· Consumer Ecosystem
LLY vs NVO
· GLP-1 Biopharma
AVGO vs MRVL
· Custom ASIC & Networking
VRT vs ETN
· AI Power & Thermal